US · guidance
CMS SOM App. X, Tag X-168
§482.102(b)(9) The fact that if a transplant is not provided in a Medicare-approved
transplant program it could affect the transplant recipient’s ability to have his or her
immuno-suppressive drugs paid for under Medicare Part B.
History
Rev. 200, Issued: 02-21-20; Effective: 02-21-20, Implementation: 02-21-20
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
d45b47f18903936cbb4cbbc59852d6e54a8f4694ae49152c86784bc80645709d
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.